Combotope Therapeutics and CiMaas Announce Oncology Research and License Option Agreement
Collaboration for the discovery and development of innovative cancer-specific CAR-NK products is underway, leveraging Combotope Therapeutics’ proprietary Tumor Glycoform specific […]